Cempra, Inc. (CEMP): Aisling Capital Slashes Stake as Stock Sinks

Page 9 of 9

Page 9 of 9 SEC Filing
Item 6.
Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
No material change.
Item 7.
Material to be Filed as Exhibits.
Exhibit 1:
Joint Filing Agreement dated as of February 15, 2012, as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (previously filed).
Exhibit 3:
Registration Rights Agreement, dated February 7, 2012, by and among the Issuer and the holders of Common Stock issuable upon the Conversion, as well as holders of the Warrants, listed in Exhibit A thereto, the form of which was filed and incorporated herein by reference to Exhibit 4.2 to the Issuer’s Registration Statement on Form S-1 (File No. 333-177261), filed with the SEC on October 12, 2011.

Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)

Page 9 of 9